Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Pathfinder Cells Stimulate Improved Kidney Function and Facilitate Repair of Kidney Tissue Damage Following Acute Kidney Injury Preclinical Data Published in Rejuvenation Research Suggest that...
CAMBRIDGE, Mass., Feb. 21, 2012 (GLOBE NEWSWIRE) -- Pathfinder Cell Therapy, Inc. ("Pathfinder," or "the Company") (OTCQB:PFND), a biotechnology company focused on the treatment of diabetes and...
CAMBRIDGE, Mass., Feb. 16, 2012 (GLOBE NEWSWIRE) -- Pathfinder Cell Therapy, Inc. ("Pathfinder," or "the Company") (OTCQB:PFND), a biotechnology company focused on the treatment of diseases...
CAMBRIDGE, Mass., Feb. 15, 2012 (GLOBE NEWSWIRE) -- Pathfinder Cell Therapy, Inc. ("Pathfinder," or "the Company") (OTCQB:PFND), a biotechnology company focused on the treatment of diseases...
CAMBRIDGE, Mass., Dec. 13, 2011 (GLOBE NEWSWIRE) -- Pathfinder Cell Therapy, Inc. ("Pathfinder") (OTCQB:PFND), a biotechnology company focused on the treatment of diseases characterized by...
Pathfinder Cell Therapy, Inc. Announces New Stock Ticker Symbol PR Newswire CAMBRIDGE, Mass., Sept. 16, 2011 CAMBRIDGE, Mass., Sept. 16, 2011 /PRNewswire/ -- Pathfinder Cell Therapy, Inc...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 0 | 0 | CS |
| 26 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 0 | 0 | CS |
| 52 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 986 | 1.0E-6 | CS |
| 156 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 4453 | 1.881E-5 | CS |
| 260 | -0.001299 | -99.9230769231 | 0.0013 | 0.034 | 1.0E-6 | 67958 | 0.00615835 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
